PHARMAGREEN BIOTECH INC. Accretion Expense
PHARMAGREEN BIOTECH INC. reported Accretion Expense of $9.27 thousand for the 9-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2023-08-14
- PHARMAGREEN BIOTECH INC. accretion expense for the quarter ending 2023-06-30 was $268.00, a 90.00% decline year-over-year.
- PHARMAGREEN BIOTECH INC. accretion expense for the quarter ending 2023-03-31 was $4.92K.
- PHARMAGREEN BIOTECH INC. accretion expense for the quarter ending 2022-12-31 was $4.09K.
- PHARMAGREEN BIOTECH INC. accretion expense for the quarter ending 2022-09-30 was $3.32K.
- PHARMAGREEN BIOTECH INC. accretion expense for fiscal 2022 was $9.96K.
- PHARMAGREEN BIOTECH INC. accretion expense for fiscal 2020 was $3.70K, a 185.65% increase from fiscal 2019.
- PHARMAGREEN BIOTECH INC. accretion expense for fiscal 2019 was $1.30K.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 6 month as first filed | Accretion Expense 9 month | Accretion Expense 12 month | Accretion Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-06-30 | $268.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | $5.18K derived: sum of 2 quarters · filed 2023-08-14 | $9.27K 10-Q · filed 2023-08-14 | $12.59K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2023-03-31 | $4.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-19 | $9.00K 10-Q · filed 2023-05-19 | $12.32K derived: sum of 3 quarters · filed 2023-05-19 | $15.00K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-12-31 | $4.09K 10-Q · filed 2023-02-14 | $7.41K derived: sum of 2 quarters · filed 2023-02-14 | $10.09K derived: sum of 3 quarters · filed 2023-08-14 | |||
| 2022-09-30 | $3.32K derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-17 | $6.00K derived: sum of 2 quarters · filed 2023-08-14 | $9.96K 10-K · filed 2023-01-17 | |||
| 2022-06-30 | $2.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | $6.64K 10-Q · filed 2023-08-14 | ||||
| 2022-03-31 | $3.96K 10-Q · filed 2023-05-19 | $729.00 10-Q · filed 2022-05-16 | ||||
| 2021-09-30 | $1.80K 10-Q · filed 2023-02-14 | $4.39K 10-K · filed 2021-12-29 | ||||
| 2021-03-31 | $5.19K 10-Q · filed 2021-05-24 | |||||
| 2020-09-30 | $3.45K 10-Q · filed 2021-05-24 | $3.70K 10-K · filed 2021-12-29 | ||||
| 2020-06-30 | $1.36K 10-Q · filed 2020-08-19 | |||||
| 2019-09-30 | $396.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-08 | $1.30K 10-K · filed 2021-01-08 | ||||
| 2019-06-30 | $900.00 10-Q · filed 2020-08-19 |